Document 0752
 DOCN  M9440752
 TI    HIV prevalence and risk behaviour in injecting drug users in Berlin.
 DT    9404
 AU    Stark K; Muller R; Institut fur Medisinische Statistik und;
       Informationsverarbeitung, Freie Universitat Berlin, Germany.
 SO    Forensic Sci Int. 1993 Nov;62(1-2):73-81. Unique Identifier : AIDSLINE
       MED/94131386
 AB    In injecting drug users (IDU) newly entering drug treatment centres in
       Berlin, HIV seroprevalence continuously decreased from 1985 through
       1992. A recent cross-sectional study with multi-site sampling (n = 472)
       showed significantly differing HIV prevalences by site of recruitment
       (treatment centres 6%, storefront units 20%, infectious disease clinic
       56%). In multivariate analysis, the borrowing of syringes in prison was
       the strongest independent predictor of HIV infection. A majority of the
       IDU have reduced risks of infection. However, current risk behaviour is
       common. Of all IDU, 48% reported the borrowing of syringes within the
       previous 6 months, only 13% had consequently used condoms. Current
       borrowing of syringes was associated with younger age, shorter history
       of intravenous drug use, negative HIV serostatus, and non-participation
       in methadone maintenance programmes. Continued preventive efforts
       against HIV transmission among IDU are needed.
 DE    Adult  Age Factors  Berlin/EPIDEMIOLOGY  *Blood-Borne Pathogens
       Communicable Diseases/*EPIDEMIOLOGY/ETIOLOGY/MICROBIOLOGY/  TRANSMISSION
       Condoms/UTILIZATION  Cross-Sectional Studies  Female  *Health Behavior
       Human  *HIV Seroprevalence/TRENDS  Logistic Models  Male  Mass Screening
       Methadone/THERAPEUTIC USE  Multivariate Analysis  Needle
       Sharing/STATISTICS & NUMER DATA  *Population Surveillance  Risk Factors
       *Risk-Taking  Sampling Studies  Substance Abuse Treatment Centers
       Substance Abuse, Intravenous/COMPLICATIONS/*EPIDEMIOLOGY/
       PSYCHOLOGY/REHABILITATION  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).